跳至主要内容
临床试验/RBR-5vyr8bp
RBR-5vyr8bp招募中未知

Effects of the use of Probiotics on the gut microbiota, clinical-nutritional and immunological status of patients undergoing Gastrectomy for Gastric Cancer: a randomized clinical trial

FAM- Universidade Federal do Amazonas0 个研究点开始时间: 2022年8月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 60Y(—)

入选标准

  • Inclusion criteria for groups G1 and G2: patients with indication for total or partial gastrectomy, with TNM staging = T1, T2, T3 (without neoadjuvant chemotherapy); patients with indication for gastrectomy only for cancer; ages between 18 to 60 years. Inclusion criteria for group G3 (negative-healthy control): People who do not have a family history of gastric cancer; people who are not blood type A+; people with no known co-morbidities; ages between 18 to 60 years; people of the same socioeconomic level (average level) of patients in the G1 group

排除标准

  • Exclusion criteria for groups G1 and G2: Patients previously treated for other neoplasms; patients undergoing gastrectomy in the palliative setting (bleeding or obstruction); use of probiotics and prebiotics in the last 15 days; Patients who are unable to comply with all follow-up steps; patients diagnosed with other morbidities that alter energy metabolism and food intake, such as HIV/AIDS, Diabetes Mellitus; pregnant women; Autoimmune diseases; Liver and Kidney diseases; Lactose Intolerant; Gluten; Inflammatory Bowel Diseases; Infection in force; use of antibiotics 15 days before surgery; patients who are unable to perform electrical bioimpedance because they have MCP (pacemaker); edema, pregnant women; women in the menstrual period, Titanium plaques in some part of the body; indigenous; patients who for some reason had their surgeries suspended during follow-up; patients who, due to worsening of the surgical condition, need ICU; patients who underwent mechanical colonic preparation in the last 30 days; immunosuppressed patients; Patients who are not Amazonians. Exclusion criteria for group G3 (negative-healthy control): People who are unable to comply with all the stages of follow-up; use of probiotics and prebiotics in the last 15 days; use of antibiotics 15 days before the start of the research; people who are unable to perform electrical bioimpedance because they have MCP (pacemaker); edema; pregnant women; women in the menstrual period, Titanium plaques in some part of the body; indigenous

研究者

发起方
FAM- Universidade Federal do Amazonas

相似试验